Cost-effectiveness of droxidopa in patients with neurogenic orthostatic hypotension: post-hoc economic analysis of Phase 3 clinical trial data

References

• Freeman R, Wieling W, Axelrod FB, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res 2011;21:69-72
   PubMed Web of Science ®Google Scholar
• Kaufmann H, Malamut R, Norcliffe-Kaufmann L, et al. The Orthostatic Hypotension Questionnaire (OHQ): validation of a novel symptom assessment scale. Clin Auton Res 2012;22:79-90
   PubMed Web of Science ®Google Scholar
• Northera (droxidopa). Full Prescribing Information. Deerfield, IL: Lundbeck NA Ltd, 2014
   Google Scholar
• Hauser RA, Hewitt LA, Isaacson S. Droxidopa in patients with neurogenic orthostatic hypotension associated with Parkinson's disease (NOH306A). J Parkinsons Dis 2014;4:57-65
   PubMedGoogle Scholar
• Hauser RA, Isaacson S, Lisk JP, et al. Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson's disease (nOH306B). Mov Disord 2015;30:646-54
   PubMed Web of Science ®Google Scholar
• Rowse G, Heritier S, Hewitt L. Falls during a 10-week placebo-controlled study of droxidopa for neurogenic orthostatic hypotension in Parkinson’s disease. Clin Auton Res 2014;24:230
   Google Scholar
• François C, Hauser RA, Kaufmann H, et al. Impact of reduction in falls for patients with PD and NOH: post hoc economic analyses of phase 3 clinical trial data on droxidopa. Mov Disord 2015;30:86-7
   Google Scholar
• Haines TP, Nitz J, Grieve J, et al. Cost per fall: a potentially misleading indicator of burden of disease in health and residential care settings. J Eval Clin Pract 2013;19:153-61
   PubMed Web of Science ®Google Scholar
• Roudsari BS, Ebel BE, Corso PS, et al. The acute medical care costs of fall-related injuries among the U.S. older adults. Injury 2005;36:1316-22
   PubMed Web of Science ®Google Scholar
• Davis JC, Robertson MC, Ashe MC, et al. International comparison of cost of falls in older adults living in the community: a systematic review. Osteoporos Int 2010;21:1295-306
   PubMed Web of Science ®Google Scholar
• Stevens JA, Corso PS, Finkelstein EA, et al. The costs of fatal and non-fatal falls among older adults. Inj Prev 2006;12:290-5
   PubMed Web of Science ®Google Scholar
• Bell FC, Miller ML. Life tables for the United States Social Security Area 1900–2100. United States of America Social Security Administration. http://www.ssa.gov/OACT/NOTES/as120/LifeTables_Body.html. Accessed June 24, 2015 Baltimore, MD; August 2005
   Google Scholar
• Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-42
   PubMed Web of Science ®Google Scholar
• Siderowf A, Ravina B, Glick HA. Preference-based quality-of-life in patients with Parkinson's disease. Neurology 2002;59:103-8
   PubMed Web of Science ®Google Scholar
• Iglesias CP, Manca A, Torgerson DJ. The health-related quality of life and cost implications of falls in elderly women. Osteoporos Int 2009;20:869-78
   PubMed Web of Science ®Google Scholar
• Latimer N, Dixon S, Drahota AK, et al. Cost-utility analysis of a shock-absorbing floor intervention to prevent injuries from falls in hospital wards for older people. Age Ageing 2013;42:641-5
   PubMed Web of Science ®Google Scholar
• Bertera EM, Bertera RL. Fear of falling and activity avoidance in a national sample of older adults in the United States. Health Soc Work 2008;33:54-62
   PubMed Web of Science ®Google Scholar
• Delbaere K, Crombez G, Vanderstraeten G, et al. Fear-related avoidance of activities, falls and physical frailty. A prospective community-based cohort study. Age Ageing 2004;33:368-73
   PubMed Web of Science ®Google Scholar
• Palmer CS, Schmier JK, Snyder E, et al. Patient preferences and utilities for ‘off-time’ outcomes in the treatment of Parkinson's disease. Qual Life Res 2000;9:819-27
   PubMed Web of Science ®Google Scholar
• Neumann PJ, Cohen JT, Weinstein MC. Updating cost-effectiveness–the curious resilience of the $50,000-per-QALY threshold. N Engl J Med 2014;371:796-7
   PubMed Web of Science ®Google Scholar
• World Health Organization. Cost-effectiveness Thresholds. http://www.who.int/choice/costs/CER_levels/en/. Accessed July 10, 2015 Washington, DC;
   Google Scholar
• International Monetary Fund. World Economic Outlook Database, April 2015. 2015. http://www.imf.org/external/pubs/ft/weo/2015/01/weodata/index.aspx. Accessed July 14, 2015 Washington, DC
   Google Scholar
• World Bank. GDP per capita, PPP (current international $), World Development Indicators database. 2015. http://data.worldbank.org/indicator/NY.GDP.PCAP.PP.CD?order=wbapi_data_value_2013+wbapi_data_value+wbapi_data_value-last&sort=desc. Accessed July 14, 2015 Washington, DC
   Google Scholar
• Wielinski CL, Erickson-Davis C, Wichmann R, et al. Falls and injuries resulting from falls among patients with Parkinson's disease and other parkinsonian syndromes. Mov Disord 2005;20:410-15
   PubMed Web of Science ®Google Scholar
• Carroll NV, Delafuente JC, Cox FM, et al. Fall-related hospitalization and facility costs among residents of institutions providing long-term care. Gerontologist 2008;48:213-22
   PubMed Web of Science ®Google Scholar
• Heinrich S, Rapp K, Rissmann U, et al. Cost of falls in old age: a systematic review. Osteoporos Int 2010;21:891-902
   PubMed Web of Science ®Google Scholar
• Sorensen SV, de Lissovoy G, Kunaprayoon D, et al. A taxonomy and economic consequences of nursing home falls. Drugs Aging 2006;23:251-62
   PubMed Web of Science ®Google Scholar
• Nurmi I, Sihvonen M, Kataja M, et al. Falls among institutionalized elderly–a prospective study in four institutions in Finland. Scand J Caring Sci 1996;10:212-20
   PubMed Web of Science ®Google Scholar
• Irvine L, Conroy SP, Sach T, et al. Cost-effectiveness of a day hospital falls prevention programme for screened community-dwelling older people at high risk of falls. Age Ageing 2010;39:710-16
   PubMed Web of Science ®Google Scholar
• Craig J, Murray A, Mitchell S, et al. The high cost to health and social care of managing falls in older adults living in the community in Scotland. Scott Med J 2013;58:198-203
   PubMed Web of Science ®Google Scholar
• Allcock LM, Rowan EN, Steen IN, et al. Impaired attention predicts falling in Parkinson's disease. Parkinsonism Relat Disord 2009;15:110-15
   PubMed Web of Science ®Google Scholar
• Basic D, Hartwell TJ. Falls in hospital and new placement in a nursing home among older people hospitalized with acute illness. Clin Interv Aging 2015;10:1637-43
   PubMed Web of Science ®Google Scholar
• Tinetti ME, Williams CS. Falls, injuries due to falls, and the risk of admission to a nursing home. N Engl J Med 1997;337:1279-84
   PubMed Web of Science ®Google Scholar
• Bowling A, Seetai S, Morris R, et al. Quality of life among older people with poor functioning. The influence of perceived control over life. Age Ageing 2007;36:310-15
   PubMed Web of Science ®Google Scholar
• Parsaik AK, Singh B, Altayar O, et al. Midodrine for orthostatic hypotension: a systematic review and meta-analysis of clinical trials. J Gen Intern Med 2013;28:1496-503
   PubMed Web of Science ®Google Scholar
• Laramee P, Brodtkorb TH, Rahhali N, et al. The cost-effectiveness and public health benefit of nalmefene added to psychosocial support for the reduction of alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels: a Markov model. BMJ Open 2014;4:e005376
   PubMed Web of Science ®Google Scholar
• Stevenson M, Pandor A, Stevens JW, et al. Nalmefene for reducing alcohol consumption in people with alcohol dependence: an evidence review group perspective of a NICE single technology appraisal. Pharmacoeconomics 2015;33:833-47
   PubMed Web of Science ®Google Scholar
• Study to assess the clinical benefit and safety of droxidopa in Parkinson’s Disease 2015. https://clinicaltrials.gov/ct2/show/study/NCT02066571. Accessed December 16, 2015
   Google Scholar
• Devos D, Moreau C, Dujardin K, et al. New pharmacological options for treating advanced Parkinson's disease. Clin Ther 2013;35:1640-52
   PubMed Web of Science ®Google Scholar
• Rudzinska M, Bukowczan S, Stozek J, et al. Causes and consequences of falls in Parkinson disease patients in a prospective study. Neurol Neurochir Pol 2013;47:423-30
   PubMed Web of Science ®Google Scholar
• Buxton MJ, Drummond MF, Van Hout BA, et al. Modelling in economic evaluation: an unavoidable fact of life. Health Econ 1997;6:217-27
   PubMed Web of Science ®Google Scholar